HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Emmanouil Peros Selected Research

Apoprotein(a) (Apolipoprotein (a))

4/2005Analysis of the apolipoprotein(a) size polymorphism in patients with systemic lupus erythematosus.
12/2004Significance of apolipoprotein(a) phenotypes in acute coronary syndromes: relation with clinical presentation.
8/2004Association between low-molecular weight apolipoprotein(a) isoforms and obesity in Italian women.
2/2004Apolipoprotein(a) null phenotype is related to a delayed age at onset of Alzheimer's disease.
2/2004Apolipoprotein(a) phenotypes are reliable biomarkers for familial aggregation of coronary heart disease.
1/2004Relation of apolipoprotein(a) size to alzheimer's disease and vascular dementia.
12/2003Association between small apolipoprotein(a) isoforms and frontotemporal dementia in humans.
12/2003Relationship between apolipoprotein(a) size polymorphism and coronary heart disease in overweight subjects.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Emmanouil Peros Research Topics

Disease

4Acute Coronary Syndrome
11/2007 - 12/2004
3Coronary Disease (Coronary Heart Disease)
06/2004 - 12/2003
3Alzheimer Disease (Alzheimer's Disease)
06/2004 - 01/2004
2Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy)
06/2004 - 01/2004
2Dementia (Dementias)
06/2004 - 01/2004
1Hypertension (High Blood Pressure)
04/2010
1Type 2 Diabetes Mellitus (MODY)
05/2005
1Metabolic Syndrome (Dysmetabolic Syndrome X)
05/2005
1Insulin Resistance
05/2005
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
04/2005
1Obesity
08/2004
1Thrombosis (Thrombus)
03/2004
1Ischemia
02/2004
1Stroke (Strokes)
01/2004
1Frontotemporal Dementia (Semantic Dementia)
12/2003
1Overweight
12/2003

Drug/Important Bio-Agent (IBA)

8Apoprotein(a) (Apolipoprotein (a))IBA
04/2005 - 12/2003
6Apolipoproteins AIBA
12/2004 - 12/2003
6Protein Isoforms (Isoforms)IBA
08/2004 - 12/2003
3Matrix Metalloproteinases (MMPs)IBA
11/2007 - 01/2007
3Lipoprotein(a)IBA
12/2004 - 12/2003
2Tissue Inhibitor of Metalloproteinase-2IBA
11/2007 - 07/2007
2Metalloproteases (Metalloproteinases)IBA
07/2007 - 01/2007
2Biomarkers (Surrogate Marker)IBA
06/2004 - 02/2004
1Renin InhibitorsIBA
04/2010
11,4-dihydropyridine (dihydropyridine)IBA
04/2010
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
04/2010
1Antihypertensive Agents (Antihypertensives)IBA
04/2010
1Calcium Channel Blockers (Blockers, Calcium Channel)IBA
04/2010
1DiureticsIBA
04/2010
1Drug CombinationsIBA
04/2010
1ReninIBA
04/2010
1Angiotensin Receptor AntagonistsIBA
04/2010
1Tissue Inhibitor of Metalloproteinase-1IBA
11/2007
1Tissue Inhibitor of MetalloproteinasesIBA
07/2007
1Hypoglycemic Agents (Hypoglycemics)IBA
05/2005
1Metformin (Glucophage)FDA LinkGeneric
05/2005
1Glucose (Dextrose)FDA LinkGeneric
05/2005
1Plasminogen Activator Inhibitor 1IBA
05/2005
1Rosiglitazone (Avandia)FDA Link
05/2005
1rosiglitazone-metformin combinationFDA Link
05/2005
1glimepiride (Amarel)FDA LinkGeneric
05/2005
1CytokinesIBA
06/2004
1OsteoprotegerinIBA
06/2004
1Genetic Markers (Genetic Marker)IBA
03/2004
1Glycoproteins (Glycoprotein)IBA
02/2004
1diazonaphthalenedisulfonic acid (NDS)IBA
01/2004
1Lipoproteins (Lipoprotein)IBA
01/2004

Therapy/Procedure

1Therapeutics
05/2005
1Glycemic Control
05/2005
1Renal Dialysis (Hemodialysis)
03/2004